EP4027973
Lyfjadreifingarsamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.9.2020EP published:
5.11.2025EP application number:
20772437.8
EP translation filed:
12.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
10.9.2040Expiry date:
10.9.2026
Title in English:
DRUG DELIVERY FORMULATIONSLanguage of the patent:
English
Timeline
Today
11.9.2020EP application
5.11.2025EP Publication
12.1.2026Translation submitted
11.2.2026Registration published
10.9.2026Expires
Owner
Name:
MEDINCELL S.A.Address:
3 rue des Frères Lumière, 34830 Jacou, FR
Inventor
Name:
RECH, AnthonyAddress:
34130 Saint Aunès, FR
Name:
ROBERGE, ChristopheAddress:
34920 Le Crès, FR
Name:
HARARY, EranAddress:
42504 Netanya, IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962900061 PDate:
13.9.2019Country:
US
Classification
Categories:
A61K 9/00, A61K 47/20, A61K 47/34, A61P 25/18, A61K 31/519